{
  "id": 18288294,
  "title": "STAT+: In China, a flood of controversial clinical trials slows to a trickle",
  "url": "https://urgent.news/2026/11/05/stat-in-china-a-flood-of-controversial-clinical-trials-slows-to-a",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T09:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/11/05/china-biotech-restrictions-impact-rare-disease-investigator-initiated-trial/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}